$DJIA$NASDAQ$MESO announced today that Remestemcel-L has been effectively used against COVID-19 in China. Mesoblast has already concluded phase 3 trials and filed a BLA with the FDA in January for treatment of GVHD in children, approval which is anticipated 1H 2020.
Separate approval would be needed for COVID-19 but all the heavy lifting is final. investorsmedia.mesoblast.co...smh.com.au/business/compan
From Yahoo chat:C_bagger1m$DJIA$NASDAQ$MESO announced today that...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.030(2.73%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.21 | $1.05 | $28.73M | 25.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14264 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 24626 | 3 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
-0.030 ( 2.52 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.21 | $1.05 | 5190842 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| MSB (ASX) Chart |